CSIMarket
 
Organicell Regenerative Medicine Inc   (BPSR)
Other Ticker:  
 
 

Organicell Regenerative Medicine Inc Growth Comparisons

Select each growth Category to receive further Information



BPSR Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 78.27% 41.33% 26.91% 29.51%
Q / Q Revenue Growth (Q2 MRQ) 14.46% 13.68% 6.71% 5.31%
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 84.89% 55.28% 17.52% %
Seq. Revenue Growth (for 12 months ending Q2 TTM) 13.92% 1.84% 5.13% 6.26%
Revenue 5 Year Average Growth 83.31% 8.66% 9.2% 7.79%
Expected Revenue Growth (Y/Y) - - 1.89% 0.98%


BPSR's Growth Comparisons in III. Quarter 2021




Facing 78.27% year on year sales decrease in the third quarter 2021, to $ 1 millions, Organicell Regenerative Medicine Inc reported smaller declines than the Biotechnology & Pharmaceuticals industry with 41.33%, and less than 26.91% increase in the Healthcare sector. Comparing third quarter sales growth, both Biotechnology & Pharmaceuticals industry and Organicell Regenerative Medicine Inc outperformed 29.51% overall market increase.

Top-line improved by 14.46% from the second quarter. Looking into annual sales rise of 83.31%, and S & P 500's average yearly sales growth is 7.79% over the five years, including only Businesses with the third quarter 2021 Results. Organicell Regenerative Medicine Inc grew faster than the market.


Growth Rates of BPSR's Income in the third quarter 2021


BPSR Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) - - 163.42% 134.3%
Seq. Operating Income Change (Q2 MRQ) - 25.57% 5.65% 2.71%
Y / Y Operating Income Growth (Q2 TTM) - 145.88% 28.8% 30.53%
Seq. Operating Income Growth (Q2 TTM) - 50.32% 24.73% 21.53%
Operating Income 5 Year Avg. Change - -10.27% 2.31% 8.51%


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) - - 337.05% 238.77%
Seq. Income from Cont. Ops. Change (Q2 MRQ) - 15.26% 4.59% 3.19%
Y / Y Income from Cont. Ops. Change (Q2 TTM) - 109.85% 36.48% 54.95%
Seq. Income from Cont. Ops. Change (Q2 TTM) - 135.44% 37.74% 28.75%
Income from Cont. Ops. 5 Year Avg. Change - -22.55% 1.83% 1.14%

BPSR Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) - - 387.42% 266.2%
Q / Q Net Income Growth (Q2 MRQ) - 15.13% 5.54% 10.45%
Y / Y Net Income Change (Q2 TTM) - 111.33% 38.56% 59.38%
Seq. Net Income Change (Q2 TTM) - 134.38% 40.24% 31.7%
Net Income 5 Year Avg. Growth - -22.29% 2.28% 1.51%

BPSR's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) - - 337.05% 238.77%
Seq. EPS from Cont. Ops. Change (Q2 MRQ) - -6.5% 4.59% 3.19%
Y / Y EPS from Cont. Ops. Change (Q2 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q2 TTM) - - -0.05% 17426.27%
EPS from Cont. Ops. 5 Year Avg. Growth - -42.55% 1.83% 1.14%



BPSR EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) - - 387.42% 1.14%
Q / Q EPS Net Growth (Q2 MRQ) - -6.6% 5.54% 10.45%
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 14727.33%
Seq. EPS Net Change (for 12 months ending Q2 TTM) - - - 17731.53%
EPS Net 5 Year Avg. Change - -22.29% 2.28% 1.51%
Expected EPS Growth (Y/Y) - - 123.59% 14.14%



Organicell Regenerative Medicine Inc reported bottom-line of $ 0.00 in the third quarter, compare to $ 0.00 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry grew by 41.33%, while Healthcare sector increased by 387.42%, and overall market improved by 266.2%.

Bottom-line improved by 14.46% from the second quarter. Looking into annual income per share rise of 83.31%, and S & P 500's average yearly income per share growth is 1.51% over the five years, including only Businesses with the third quarter 2021 earnings reports. Organicell Regenerative Medicine Inc grew faster than the market.

BPSR Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) - 49.26% 1.32% 22.14%
Seq. Free Cash Flow Change (Q2 MRQ) - 8.25% 20.89% 80.91%
Y / Y Free Cash Flow Change (Q2 TTM) - 56.72% 16.6% -5.26%
Seq. Free Cash Flow Change (Q2 TTM) - 12.56% 1.05% 6.05%
Free Cash Flow 5 Year Avg. Change - 0.79% 13.18% 18.43%

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - -7.61% -
Seq. Net Cash Flow Change (Q2 MRQ) - -92.18% - -
Y / Y Net Cash Flow Change (Q2 TTM) - 64.39% -82.05% -83.55%
Seq. Net Cash Flow Change (Q2 TTM) - - 66.47% -71.94%
Net Cash Flow 5 Year Avg. Change 35.85% - 41.58% 125.08%

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 87.03% 33.24% 10.33% 11.07%
Seq. Capital Expenditures Change (Q2 MRQ) - -1.46% 0.44% -2.5%
Y / Y Capital Expenditures Change (Q2 TTM) 62.09% 48.66% 11.26% -4.92%
Seq. Capital Expenditures Change (Q2 TTM) 58.62% 24.12% 3.32% 0.23%
Capital Expenditures 5 Year Avg. Change - 986.28% 273.26% 86.93%

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 





       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ILLU's Profile

Stock Price

ILLU's Financials

Business Description

Fundamentals

Charts & Quotes

ILLU's News

Suppliers

ILLU's Competitors

Customers & Markets

Economic Indicators

ILLU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071